Patent · US Active

Synthesis of copanlisib and its dihydrochloride salt

US10035803B2 · kind B2 · utility

7Cited by

3References

25Claims

0Family size

Assignee

Bayer Pharma Aktiengesellschaft · DE

Inventors

Jan-Georg Peters · Solingen, DE
Jürgen Stiehl · Winsen (Aller), DE
Kai Lovis · Düsseldorf, DE

Key dates

Filing date	Nov 5, 2015
Grant date	Jul 31, 2018
Priority date	—
Expiry date	Nov 5, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D295/088
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to a novel method of preparing copanlisib, and copanlisib dihydrochloride, to novel intermediate compounds, and to the use of said novel intermediate compounds for the preparation of said copanlisib.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.